Auflichtmikroskopische Untersuchung melanozytärer Nävi vor und ...

Garbe C, Büttner P, Weiß J, Soyer HP, Stocker U, Krüger S, Roser M, Weckbecker J,
Panizzon R, Bahmer F, Tilgen W, Guggenmoos-Holzmann I, Orfanos CE:
Risk Factors for Developing Cutaneous Melanoma and Criteria for Identifying Persons
at Risk: Multicenter Case-Control Study of the Central Malignant Melanoma Registry of
the German Dermatological Society. J Invest Dermatol 102, 695-699 (1994)
Garbe C: Epidemiologie des malignen Melanoms.
In: Waclawiczek HW, Gebhart W, Manfreda D, Schlag P:
Das maligne Melanom-Derzeitiger Stand in Diagnose und Therapie
1.Auflage, 1, Springer, Berlin, 1991
Garbe C:
Zunehmende Häufigkeit des malignen Melanoms:
Hautarzt 51, 518 (2000)
Hofmann-Wellenhof R, Wolf P, Smolle J, Reimann-Weber A, Soyer H P, Kerl H:
Influence of UVB therapy on dermoscopic features of acquired melanocytic nevi.
J Am Acad Dermatol 37, 559-563 (1997)
Hofmann-Wellenhof R, Soyer H P, Wolf I, Smolle J, Reischle S, Rieger E,Kenet R O,
Wolf P,Kerl. H:
Ultraviolet Radiation of Melanocytic Nevi. Arch Dermatol 134, 845-850 (1998)
Holly EA, Kelly JW, Shpall SN, Chiu SH:
Number of melanocytic nevi as a major risk factor for malignant melanoma.
J Am Acad Dermatol 17, 459-468 (1987)
Jemal A, Devesa SS, Hartge P, Tucker MA:
Recent Trends in Cutaneous Melanoma Incidence Among Whites in the United States.
J Natl Canc Inst 93 (9) , 678-683 (2001)
32